Concepedia

Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)

M. J. Birrer, Heather A. Lankes, Robert A. Burger, Robert S. Mannel, Howard D. Homesley, Volkmar Henschel, Mika A. Sovak, S.J. Scherer, SL de Haas, Céline Pallaud

Annals of Oncology · 2012 · 10 citations · 0 references

DOI

Concepts